See the Complete Picture.

Published 2 days ago • loading... • Updated 2 days ago

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

Summary by Charleston Gazette-Mail

WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

62 Articles

62 Articles

All

Left

8

Center

15

Right

6

The Courier-Tribune

+60 Reposted by 60 other sources

Vanda Pharmaceuticals Announces Participation in the Mizuho Neuro & Ophthalmology Summit 2025

WASHINGTON, May 16, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the company will participate in investor meetings at the Mizuho Neuro & Ophthalmology Summit 2025 in New York City on Wednesday, May 21, 2025.

2 days ago

Read Full Article

Vanda Pharmaceuticals Sets Key Investor Meetings at Major Neuro & Ophthalmology Conference Next Week

Vanda executives to discuss pipeline developments and strategy at exclusive Mizuho healthcare conference. Learn about potential catalysts in neuro portfolio. Get insights.

2 days ago

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Coverage Details

Total News Sources62

Leaning Left8Leaning Right6Center15Last Updated23 hours agoBias Distribution

52% Center

Bias Distribution

52% of the sources are Center

52% Center

+3

+10

Untracked bias

+24

Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Charleston Gazette-Mail broke the news in Charleston, United States 2 days ago on Friday, May 16, 2025.

Sources are mostly out of (0)

Similar News Topics

Similar News Topics